About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Alembic Pharmaceuticals Ltd.
BSE Code 533573
ISIN Demat INE901L01018
Book Value 264.28
NSE Code APLLTD
Dividend Yield % 1.13
Market Cap 190980.73
P/E 37.96
EPS 25.60
Face Value 2  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Mar 2025Dec 2024Sep 2024Jun 2024
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 15706.40 14060.90 15803.50 14755.60
Total Expenditure 13999.80 12262.60 13208.60 11841.30
PBIDT (Excl OI) 1706.60 1798.30 2594.90 2914.30
Other Income 132.10 154.60 160.60 31.40
Operating Profit 1838.70 1952.90 2755.50 2945.70
Interest 237.10 217.90 182.80 126.90
Exceptional Items 0 0 128.70 0
PBDT 1601.60 1735.00 2701.40 2818.80
Depreciation 686.00 696.90 701.20 686.80
Profit Before Tax 915.60 1038.10 2000.20 2132.00
Tax 162.20 180.00 342.40 370.10
Provisions and contingencies 0 0 0 0
Profit After Tax 753.40 858.10 1657.80 1761.90
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 753.40 858.10 1657.80 1761.90
Equity Capital 393.10 393.10 393.10 393.10
Face Value (IN RS) 2 2 2 2
Reserves    
Calculated EPS 3.83 4.37 8.43 8.96
Calculated EPS (Annualised) 15.33 17.46 33.74 35.86
No of Public Share Holdings 59616534.00 59734871.00 59734871.00 59734871.00
% of Public Share Holdings 30.33 30.39 30.39 30.39
     
PBIDTM% (Excl OI) 10.87 12.79 16.42 19.75
PBIDTM% 11.71 13.89 17.44 19.96
PBDTM% 10.20 12.34 17.09 19.10
PBTM% 5.83 7.38 12.66 14.45
PATM% 4.80 6.10 10.49 11.94
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.